Examkin

Question

Difficulty: HardHealthcare Economics and Value-Based Care

A 64-year-old man is evaluated in the outpatient clinic for a routine health maintenance visit. He has a history of primary hypertension and hyperlipidemia. His current medications include lisinopril and atorvastatin. He has a 30-pack-year smoking history but successfully quit 5 years ago. The patient is active, walks 2 miles daily without any chest pain, dyspnea, palpitations, or claudication, and has no history of cardiovascular disease. Vital signs include a blood pressure of 124/78 mm Hg, a heart rate of 72/min, and a BMI of 27 kg/m². Cardiovascular and pulmonary examinations are unremarkable. Recent laboratory results show a low-density lipoprotein (LDL) cholesterol level of 85 mg/dL and a hemoglobin A1c of 5.6%. During the visit, the patient mentions he recently read a news article about 'silent heart attacks' and requests a cardiac stress test to 'make sure my heart is in good shape.' In the context of high-value, cost-conscious care, which of the following is the most appropriate next step in management?

  1. Reassure the patient, continue his current medication regimen, and advise against cardiac testing.Answer
  2. B
    Order a non-contrast computed tomography scan for coronary artery calcium scoring to risk-stratify the patient.
  3. C
    Schedule an exercise treadmill electrocardiogram to ensure the absence of exercise-induced ischemia.
  4. D
    Perform a resting 12-lead electrocardiogram in the clinic today as a baseline screening tool.
  5. E
    Refer the patient to a cardiologist for specialized cardiovascular evaluation and risk assessment.

Answer

The most appropriate next step is to reassure the patient, continue his current medications, and advise against cardiac testing.
The correct approach is to avoid unnecessary testing and reassure the patient. Principles of healthcare economics and value-based care emphasize minimizing interventions that do not improve patient outcomes but increase costs and risks. The Choosing Wisely campaign and the US Preventive Services Task Force (USPSTF) advise against routine screening with resting or stress electrocardiography in asymptomatic patients. This patient is at baseline risk, entirely asymptomatic, and his known risk factors (hypertension, hyperlipidemia) are already medically optimized. Testing in this population has a low predictive value and a high false-positive rate, frequently leading to a 'testing cascade' of unnecessary invasive procedures like coronary angiography, which exposes the patient to contrast nephropathy, bleeding, and increased financial burden without a demonstrated mortality benefit.

Step-by-Step Solution

1
Assess the patient's clinical status and pre-test probability for coronary artery disease.
The patient is completely asymptomatic, has excellent functional capacity (walks 2 miles daily), and has well-controlled risk factors (hypertension and hyperlipidemia on medication).
Determining symptomatic status is required to decide between screening (asymptomatic) versus diagnostic testing (symptomatic).
2
Evaluate the patient's request against evidence-based guidelines for high-value care (e.g., Choosing Wisely, USPSTF).
Guidelines strongly recommend against routine cardiac screening (resting ECG, stress testing) in asymptomatic patients.
Screening low-risk, asymptomatic populations yields a high false-positive rate, triggering a cascade of unnecessary, expensive, and potentially harmful invasive procedures (e.g., cardiac catheterization).
3
Consider if alternative testing (e.g., CAC score) would alter clinical management.
A CAC score would not change management because the patient is already on optimized statin and antihypertensive therapy.
High-value care dictates that a diagnostic or imaging test should only be ordered if the result will meaningfully change the patient's management plan.

Key Concept

High-Value Care in Cardiovascular Screening
Rate this question

Topics

Healthcare Economics and Value-Based Care

More questions from this topic